Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803]. (April 2022) - De Bellis, Eleonora; Imbergamo, Silvia; Candoni, Anna; Liço, Albana; Tanasi, Ilaria; Mauro, Endri; Mosna, Federico; Leoncin, Matteo; Stulle, Manuela; Griguolo, Davide; Pravato, Stefano; Trentin, Livio; et al.